Possible impact of aprotinin on post-cardiothoracic surgery atrial fibrillation.
Gillespie
Effie L
EL
Department of Pharmacy Services, Hartford Hospital, Hartford, USA.
Perkerson
Kristen A
KA
White
C Michael
CM
Coleman
Craig I
CI
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D013504:Cardiovascular Surgical Procedures / Q000009:adverse effects*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy / Q000276:immunology
D000889:Anti-Arrhythmia Agents; D007611:Aprotinin